Synercid is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Quinupristin; Dalfopristin.
| Product ID | 61570-260_1189d9dc-f581-40c6-af58-b1bfff4d2497 |
| NDC | 61570-260 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Synercid |
| Generic Name | Quinupristin And Dalfopristin |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 1999-09-21 |
| Marketing Category | NDA / NDA |
| Application Number | NDA050748 |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Substance Name | QUINUPRISTIN; DALFOPRISTIN |
| Active Ingredient Strength | 150 mg/5mL; mg/5mL |
| Pharm Classes | Streptogramin Antibacterial [EPC],Streptogramins [CS],Streptogramin Antibacterial [EPC],Streptogramins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 1999-09-21 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA050748 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1999-09-21 |
| Marketing Category | NDA |
| Application Number | NDA050748 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2013-10-07 |
| Ingredient | Strength |
|---|---|
| QUINUPRISTIN | 150 mg/5mL |
| SPL SET ID: | 28f698df-b584-4455-2e94-6efc41313960 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() SYNERCID 75491359 2396275 Live/Registered |
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, LLC 1998-05-27 |
![]() SYNERCID 74230447 1772760 Live/Registered |
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, LLC 1991-12-16 |